Advertisement
Advertisement
U.S. Markets open in 1 hr 25 mins
Advertisement
Advertisement
Advertisement
Advertisement

Zentek Ltd. (ZEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
2.5900-0.1400 (-5.13%)
At close: 03:59PM EDT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.7300
Open2.6800
Bid2.5900 x 0
Ask2.6000 x 0
Day's Range2.5900 - 2.7500
52 Week Range2.1500 - 7.5000
Volume15,205
Avg. Volume47,072
Market Cap240.143M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-0.3930
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
  • ACCESSWIRE

    Zentek Provides Update on Commercial Partnerships

    Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, provides the following updates on its commercial agreements relating to its proprietary ZenGUARD™ antimicrobial coating.

  • ACCESSWIRE

    Zentek Files a Provisional Patent on the use of ZenGUARD(TM) as an Anti-Inflammatory Agent

    Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has filed a provisional patent on the use of ZenGUARD™ as an anti-inflammatory agent for dermatological conditions. "We continue to work diligently to secure patents for our various intellectual property," said Greg Fenton, CEO for Zentek.

  • ACCESSWIRE

    Zentek Announces Appointment of New Board Director

    GUELPH, ON / ACCESSWIRE / July 5, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Ilse Treurnicht to its Board of Directors.

Advertisement
Advertisement